Markets.com Logo

ARTH

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0008$
  • Previous Close
    0.0008$
  • 52 Week Change
    1.20$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0001$ - 1.2$
  • Dividend Per Share
    --
  • Market cap
    444$
  • EPS
    -1.4366
  • Beta
    4.028
  • Volume
    --

About

ARTH.US represents the stock of Arcutis Biotherapeutics, Inc., a commercial-stage biopharmaceutical company focused on developing and commercializing novel treatments for immune-mediated skin diseases. Arcutis's key product is ZORYVE (roflumilast) topical cream, approved for the treatment of plaque psoriasis in adults and adolescents, and they are actively pursuing further indications and formulations of roflumilast and other therapies for conditions like atopic dermatitis and seborrheic dermatitis. The ".US" suffix indicates that the stock is traded on a United States stock exchange.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

ARTH.US's price, like any publicly traded stock, is swayed by multiple factors. Company Performance: ARTH's financial health, including revenue, earnings, and profit margins directly influences investor perception and valuation. Positive performance typically boosts the stock price. Market Sentiment: Overall market trends and investor optimism or pessimism can significantly impact ARTH's price. A bullish market may lift ARTH even without specific positive news, while a bearish one can drag it down. Industry Trends: The performance and outlook of the broader industry to which ARTH belongs affect investor confidence. Favorable industry trends can make ARTH more attractive, conversely, unfavorable trends can deter investors. Economic Conditions: Macroeconomic factors such as interest rates, inflation, and economic growth can impact ARTH's valuation. A strong economy usually supports higher stock prices. News and Events: Significant news related to ARTH, such as product launches, acquisitions, or regulatory changes, can trigger immediate price reactions. Positive news typically increases demand and vice versa.

People Also Watch

Latest news

Stock Market Today: IonQ, Rigetti, D-Wave, What’s going on with Quantum Computing Stocks?

Stock Market Today: IonQ, Rigetti, D-Wave, What’s going on with Quantum Computing Stocks?

Ghko B|--
Gold Price Today, April 7: XAU/USD Hovers Near $4,660 Ahead of Key US Inflation Data

Gold Price Today, April 7: XAU/USD Hovers Near $4,660 Ahead of Key US Inflation Data

Ghko B|--

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--